Ensemble Therapeutics

Novartis AG ’s head of pharmaceuticals David Epstein attracted attention in late October by announcing the Swiss group intends to become a leader in developing treatments for multiple sclerosis, tell

Deciphera Pharmaceuticals LLC has reached the point in a biotech’s lifecycle when it transitions from scientific leadership to business leadership: on April 7, it moved its founding CEO over to the

A series of recent and anticipated events is drawing attention to interleukin-17 (IL-17) and related cytokines – a set of immunological drug targets of long-standing interest to large and small compan

MUMBAI – Biocon Ltd. ’s novel anti-CD6 antibody itolizumab, branded Alzumab , has hit the shelves in India for use in the treatment of moderate-to-severe forms of plaque psoriasis. The much-awaite